GROW® Group is a British start-up unlocking the potential of cannabis medicines for those who need it. 🌱@GrowGroupUK
- Tweets704
- Following399
- Followers1.5K
- Likes1.8K
ALT what makes grow different? And what does that mean for you? Some background on who we are, what we do best, and why that makes a difference to you. Swipe to learn more about the history of GROW...
ALT 1- one of the only british GROWN & OWNED companies Founded in 2017 in London, we began at the turn of legalisation. We pride ourselves on being a British company. Homegrown businesses bring benefits in job creation, understanding local patients, and supporting the UK economy. As one of few manufacturers, we import and package flower, vapes, oils, and more.
ALT 2- we are one of the largest manufacturers Being a manufacturer means that we can import flower, THC, and CBD. We “pack down” bulk imports of medicines into individual packaging for patients. Since acquiring a new manufacturing facility last year, we have built capabilities to support patients in receiving new and existing formulations of medicines. Local UK operations provide time savings in getting medicines to you, as well as tracing exact standards.
ALT 3- our rich history GROW completed the first ever import of CBMPs into this country. Having been in this industry since the start, we understand its complexity and the importance of keeping supply consistent for patients. Since then we have focused on expanding distribution and manufacturing, including developing new forms of administration, to widen the potential of medicines and to make them more accessible.
ALT 4- our passionate team Every single staff member appreciates and understands the importance of the work we do. This is key to running a medical c*nn*bis company. Many of our team are patients who provide feedback, which we value along with all vital feedback that we recieve. We are dedicated to the potential of c*nn*bis medicines. With many life experiences, backgrounds, and skills, we are united behind our one goal of creating a world where CBMPs are obtainable to every patient who will benefit from them.
